Information Provided By:
Fly News Breaks for April 20, 2016
UNH
Apr 20, 2016 | 07:29 EDT
Oppenheimer analyst Michael Wiederhorn raised his price target for UnitedHealth to $145 from $140 after the company announced its Q1 results. Despite remaining a concern, the Exchange business is non-core and will quickly turn into a tailwind in 2017 as the losses subside, the analyst tells investors in a research note. Wiederhorn continues to favor UnitedHealth given its operational track record, well-positioned Optum business, and exposure to fast-growing Government businesses. The analyst reiterates an Outperform rating on the shares.
News For UNH From the Last 2 Days
UNH
Apr 19, 2024 | 04:50 EDT
Deutsche Bank analyst George Hill raised the firm's price target on UnitedHealth to $562 from $545 and keeps a Buy rating on the shares. The company reported a Q1 earnings beat with many moving pieces caused by the cyberattack on Change Healthcare, which left earnings quality and guidance up to investor interpretation, the analyst tells investors in a research note. The firm sees the full impact of the hack, as well as conservatism around cost trend and utilization would impact UnitedHealth earnings by only 2% for the full year.
UNH
Apr 18, 2024 | 09:56 EDT
Notable gainers among liquid option names this morning include Genuine Parts (GPC) $159.09 +15.03, Globe Life (GL) $66.97 +3.74, Anthem (ELV) $532.10 +23.13, United Continental (UAL) $50.59 +1.84, and UnitedHealth (UNH) $494.80 +15.81.
UNH
Apr 18, 2024 | 09:41 EDT
Unusual total active option classes on open include: Wrap Technologies (WRAP), AstraZeneca (AZN), JetBlue (JBLU), United Continental (UAL), Taiwan Semi (TSM), Nokia (NOK), EBay (EBAY), Maplebear Inc (CART), Airbnb (ABNB), and UnitedHealth (UNH).
UNH
Apr 17, 2024 | 08:11 EDT
RBC Capital analyst Ben Hendrix lowered the firm's price target on UnitedHealth to $555 from $596 but keeps an Outperform rating on the shares. The company reported a "better than feared" Q1, but the debate over utilization trends is expected to persist through the first half as excess reserves skew the medical care ratio picture, the analyst tells investors in a research note. RBC also notes that its added caution reflects UnitedHealth's "reduced claims visibility".